Compounding pharmacies' glutathione IV drips sicken over 30 across four states
The CDC and FDA report that more than 30 people in four states developed bacterial toxin poisoning after receiving intravenous glutathione treatments at wellness clinics. Investigators traced the problem to at least two compounding pharmacies that used glutathione powder graded only for oral dietary supplements—sourced from Medisca Inc.—to prepare injectable drips, rather than the sterile grade required for injection.